Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 11/2007

01.11.2007 | Concise Article

Molecular characterisation of invasive Streptococcus pyogenes isolates from Hungary obtained in 2004 and 2005

verfasst von: B. Krucsó, M. Gacs, B. Libisch, Zs. Vargáné Hunyadi, K. Molnár, M. Füzi, J. Pászti

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Our aim was to characterise by molecular techniques group A streptococci isolated from invasive infections in Hungary in 2004–2005. Twenty-six nonduplicate invasive GAS isolates were selected and examined. The mortality rate proved high (52.3%) for those cases (n = 21) where data were available. Predominant emm types were emm1 (n = 13, 50%) and emm80 (n = 5, 19.2%), but other M types (emm4, emm28, emm66, emm81.1, emm82, emm84) were also identified. Eight different PFGE types were distinguished, and each emm type showed an individual PFGE pattern. Our results show that—similarly to results obtained in several other countries—emm type 1 strains predominate among invasive GAS isolates, and that emm 1 type strains recovered from severe streptococcal infections were associated with the presence of the speA gene. The rate for macrolide resistance proved low: only two isolates showed elevated MICs for erythromycin.
Literatur
1.
Zurück zum Zitat Fischetti VA (1989) Streptococcal M protein: molecules design and biological behavior. Clin Microbiol Rev 2:285–314PubMed Fischetti VA (1989) Streptococcal M protein: molecules design and biological behavior. Clin Microbiol Rev 2:285–314PubMed
2.
Zurück zum Zitat Szita J, Káli M (1970) Type distribution of Streptococcus pyogenes in the years 1964–65 and 1968–69. Acta Microbiol Acad Sci Hung 17:347–356PubMed Szita J, Káli M (1970) Type distribution of Streptococcus pyogenes in the years 1964–65 and 1968–69. Acta Microbiol Acad Sci Hung 17:347–356PubMed
3.
Zurück zum Zitat Yu CE, Ferretti JJ (1989) Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Infect Immun 57:3715–3719PubMed Yu CE, Ferretti JJ (1989) Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Infect Immun 57:3715–3719PubMed
4.
Zurück zum Zitat The Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 269:390–391CrossRef The Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 269:390–391CrossRef
5.
Zurück zum Zitat CLSI (2005) Performance standards for antimicrobial susceptibility testing (M100-S-15); Fifteenth Informational Supplement. Clinical and Laboratory Standards Institute, West Valley Road, Suite 1400, Wayne, Pennsylvania USA CLSI (2005) Performance standards for antimicrobial susceptibility testing (M100-S-15); Fifteenth Informational Supplement. Clinical and Laboratory Standards Institute, West Valley Road, Suite 1400, Wayne, Pennsylvania USA
6.
Zurück zum Zitat Whatmore AM, Kehoe MA (1994) Horizontal gene transfer in the evolution of group A streptococcal emm like genes: gene mosaics and variation in Vir regulons. Mol Microbiol 11:363–374PubMedCrossRef Whatmore AM, Kehoe MA (1994) Horizontal gene transfer in the evolution of group A streptococcal emm like genes: gene mosaics and variation in Vir regulons. Mol Microbiol 11:363–374PubMedCrossRef
7.
Zurück zum Zitat Facklam RF, Martin DR, Lovgren M, Johnson DR, Efstratiou A, Thompson TA, Gowan S, Kriz P, Tyrrell GJ, Kaplan E, Beall B (2002) Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis 34:28–38PubMedCrossRef Facklam RF, Martin DR, Lovgren M, Johnson DR, Efstratiou A, Thompson TA, Gowan S, Kriz P, Tyrrell GJ, Kaplan E, Beall B (2002) Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis 34:28–38PubMedCrossRef
8.
Zurück zum Zitat Vlaminckx BJM, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit Ad C, Novak R, Verhoef J, Schmitz FJ (2003) Site-specific manifestations of invasive group A streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41:4941–4949PubMedCrossRef Vlaminckx BJM, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit Ad C, Novak R, Verhoef J, Schmitz FJ (2003) Site-specific manifestations of invasive group A streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41:4941–4949PubMedCrossRef
9.
Zurück zum Zitat Goering RV, Winters MA (1992) Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol 30:577–580PubMed Goering RV, Winters MA (1992) Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol 30:577–580PubMed
10.
Zurück zum Zitat Ekelund K, Skinhøj P, Madsen J, Konradsen HB (2005) Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections:results from a nationwide study. J Clin Microbiol 43:1789–1796PubMedCrossRef Ekelund K, Skinhøj P, Madsen J, Konradsen HB (2005) Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections:results from a nationwide study. J Clin Microbiol 43:1789–1796PubMedCrossRef
11.
Zurück zum Zitat Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470–511PubMedCrossRef Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470–511PubMedCrossRef
12.
Zurück zum Zitat Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C, Strep-EURO (2005) The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Eurosurveillance 10:179–184PubMed Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C, Strep-EURO (2005) The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Eurosurveillance 10:179–184PubMed
13.
Zurück zum Zitat Jasir A and Schalén C on behalf of the Strep-EURO study group (2005) Strep-EURO: progress in analysis and research into severe streptococcal disease in Europe, 2003–2004. Eurosurveillance 10:E050203.3PubMed Jasir A and Schalén C on behalf of the Strep-EURO study group (2005) Strep-EURO: progress in analysis and research into severe streptococcal disease in Europe, 2003–2004. Eurosurveillance 10:E050203.3PubMed
14.
Zurück zum Zitat Szczypa K, Sadowy E, Izdebski R, Strakova L, Hryniewicz W (2006) Group A streptococci from invasive disease episodes in Poland are remarkably divergent at the molecular level. J Clin Microbiol 44:3975–3979PubMedCrossRef Szczypa K, Sadowy E, Izdebski R, Strakova L, Hryniewicz W (2006) Group A streptococci from invasive disease episodes in Poland are remarkably divergent at the molecular level. J Clin Microbiol 44:3975–3979PubMedCrossRef
15.
Zurück zum Zitat Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit C, Hafner D, Novak R (2003) Toxin-gene profile heterogeneity among endemic invasive European group A Streptococcal isolates. J Infect Dis 188:1578–1586PubMedCrossRef Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit C, Hafner D, Novak R (2003) Toxin-gene profile heterogeneity among endemic invasive European group A Streptococcal isolates. J Infect Dis 188:1578–1586PubMedCrossRef
Metadaten
Titel
Molecular characterisation of invasive Streptococcus pyogenes isolates from Hungary obtained in 2004 and 2005
verfasst von
B. Krucsó
M. Gacs
B. Libisch
Zs. Vargáné Hunyadi
K. Molnár
M. Füzi
J. Pászti
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2007
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0359-4

Weitere Artikel der Ausgabe 11/2007

European Journal of Clinical Microbiology & Infectious Diseases 11/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.